Report #2835813

Overview

Sex

Unknown

Age

Age unknown

State

FL

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

patients were getting Shingrix (2nd dose) a year later; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Patient had first dose a year ago). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: patients were getting Shingrix (2nd dose) a year later). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 31-MAR-2025 Pharmacist reported that during COVID, patients were getting Shingrix (2nd dose) a year later. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccinations schedule.